Clinical trials
Phase 2 Cutaneous Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 8 |
| Recruiting | 6 |
| Active, not recruiting | 5 |
| Withdrawn | 5 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Regeneron Pharmaceuticals | 3 |
| Massachusetts General Hospital | 2 |
| Stanford University | 2 |
| The Netherlands Cancer Institute | 2 |
| AHS Cancer Control Alberta | 1 |
| Fondazione Melanoma Onlus | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Henan Cancer Hospital | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cutaneous Squamous Cell Carcinoma | 35 |
| Skin Neoplasms | 10 |
| Carcinoma, Squamous Cell | 6 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Keratosis, Actinic | 3 |
| Neoplasm Metastasis | 3 |
| Basal Cell Carcinoma | 2 |
| Carcinoma | 2 |
| Carcinoma, Merkel Cell | 2 |
Trials
Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.